Skip to content

Clinical trials

Retinal Vein Occlusion trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20115
20124
20141
20161
20171
20192
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Allergan3
Hoffmann-La Roche3
National Eye Institute (NEI)2
Annexin Pharmaceuticals AB1
Bayer1
Clearside Biomedical, Inc.1
Guy's and St Thomas' NHS Foundation Trust1
University of Iceland1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion21
Macular Edema13
Vision Disorders5
Macular Degeneration1
Uveitis, Posterior1
Wet Macular Degeneration1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.